Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 1, 2016, Pages 127-130

  Cheong, Kai Ning ^a   Chiu, Susan S ^a   Chan, Betsy Wai Ka ^a   To, Kelvin Kai Wang ^a   Chan, Eunice Lai Yin ^a   Ho, Pak Leung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atypical pneumonia; Empyema; Macrolides

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BACTERIAL RNA; CEFTRIAXONE; CLARITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MACROLIDE; RNA 23S; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MACROLIDE RESISTANT MACOPLASMA PNEUMONIAE PNEUMONIA; MACROLIDE SENSITIVE MYCOPLASMA PNEUMONIAE PNEUMONIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; DRUG EFFECTS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PRESCHOOL CHILD; TREATMENT FAILURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MACROLIDES; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; TREATMENT FAILURE;

EID: 84958059627     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.11.003     Document Type: Article

References (10)

1. Principi N., Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 2013, 68:506-511.
2. To K.K., Chan K.H., Fung Y.F., Yuen K.Y., Ho P.L. Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia. Eur Respir J 2010, 36:969-971.
3. Okada T., Morozumi M., Tajima T., Hasegawa M., Sakata H., Ohnari S., et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012, 55:1642-1649.
4. Chan K.H., To K.K., Chan B.W., Li C.P., Chiu S.S., Yuen K.Y., et al. Comparison of pyrosequencing, Sanger sequencing, and melting curve analysis for detection of low-frequency macrolide-resistant Mycoplasma pneumoniae quasispecies in respiratory specimens. J Clin Microbiol 2013, 51:2592-2598.
5. Zhou Y., Zhang Y., Sheng Y., Zhang L., Shen Z., Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 2014, 58:1034-1038.
6. Chan K.H., Peiris J.S., Lim W., Nicholls J.M., Chiu S.S. Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. J Clin Virol 2008, 42:65-69.
7. Ho P.L., Chiu S.S., Chow F.K., Mak G.C., Lau Y.L. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong. Vaccine 2007, 25:6837-6841.
8. Bradley J.S., Byington C.L., Shah S.S., Alverson B., Carter E.R., Harrison C., et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011, 53:e25-e76.
9. Kawai Y., Miyashita N., Kubo M., Akaike H., Kato A., Nishizawa Y., et al. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother 2013, 57:2252-2258.
10. Spuesens E.B., Fraaij P.L., Visser E.G., Hoogenboezem T., Hop W.C., van Adrichem L.N., et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med 2013, 10:e1001444.